Pioglitazone Induced Reversible Pancytopenia

被引：4
|
作者：
Karakurt, F. [2 ]
Kargili, A. [2 ]
Kasapoglu, B. [1 ]
机构：
[1] Fatih Univ Hosp, Dept Internal Med, TR-06510 Ankara, Turkey
[2] Fatih Univ Hosp, Dept Endocrinol, TR-06510 Ankara, Turkey
来源：
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2010年 / 118卷 / 02期
关键词：
pioglitazone; diabetes mellitus type 2; pancytopenia; THIAZOLIDINEDIONES;
D O I：
10.1055/s-0029-1234065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pioglitazone is used to improve insulin sensitivity in type 2 diabetes. This group of drugs is usually well tolerated; however, their use may be associated with several adverse effects including edema, weight gain, macular edema and heart failure. Herein we report a patient who developed pancytopenia on the 7th day of oral pioglitazone treatment for the control of diabetes mellitus and fully recovered 6 days after the cessation of this drug. To the best of our knowledge this is the first reported case of pancytopenia induced by pioglitazone therapy.
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [21] Reversible Pancytopenia and Immunodeficiency in a Patient With Hereditary Folate Malabsorption
    Erlacher, Miriam
    Gruenert, Sarah Catharina
    Cseh, Annamaria
    Steinfeld, Robert
    Salzer, Ulrich
    Lausch, Ekkehart
    Nosswitz, Ulrike
    Dueckers, Gregor
    Niehues, Tim
    Ehl, Stephan
    Niemeyer, Charlotte Marie
    Speckmann, Carsten
    PEDIATRIC BLOOD & CANCER, 2015, 62 (06) : 1091 - 1094
  • [22] A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim-Sulfamethoxazole-Induced Pancytopenia
    Sawalha, Khalid
    Sobash, Philip T.
    Kamoga, Gilbert-Roy
    CLINICS AND PRACTICE, 2021, 11 (02) : 358 - 362
  • [23] Olanzapine-induced pancytopenia
    Pattichis, Andrew
    Bastiampillai, Tarun
    Nataraj, Naveen
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 (10): : 911 - 911
  • [24] Amphotericin B induced pancytopenia
    Vaish, Esha
    Gupta, Kamlesh
    Ansari, Shahnawaz
    Singh, Kaushal
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (09) : 5692 - 5695
  • [25] CLOMIPRAMINE-INDUCED PANCYTOPENIA
    MAGNI, G
    URBANI, A
    SILVESTRO, A
    GRASSETTO, M
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1987, 175 (05) : 309 - 310
  • [26] Linezolid-induced pancytopenia
    Halpern, M
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (03) : 347 - 348
  • [27] Efatizumab-induced pancytopenia
    Nosbaum, A.
    Attombert-Blaise, C.
    Ly, A.
    Jullien, D.
    Faure, M.
    Claudy, A.
    Simon, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (05): : 407 - 408
  • [28] Cotrimoxazole induced DRESS with pancytopenia
    Ben Sassi, M.
    Lakhoua, G.
    Sahnoun, R.
    Charfi, O.
    El Aidli, S.
    Daghfous, R.
    Zaiem, A.
    Kastalli, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 79 - 79
  • [29] Bupropion-induced pancytopenia
    Kim, Jowon L.
    Chercover, David
    Masoudi, Hamid
    Foltz, Lynda
    BMJ CASE REPORTS, 2024, 17 (11)
  • [30] Leflunomide-Induced Pancytopenia
    Slim, R.
    Zamy, M.
    Ben Salem, C.
    Biour, M.
    DRUG SAFETY, 2009, 32 (10) : 910 - 911
12345